Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gluconic Acid SCHEMBL14841816 | 1.00 | PDE4A (0.73) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Glucuronic Acid SCHEMBL8675875 | 1.00 | PDE4A (0.73) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Glucuronic Acid SCHEMBL2365643 | 1.00 | PDE4A (0.73) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL861904 | 1.00 | PDE4A (0.73) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL20741140 | 1.00 | PDE4A (0.73) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL2785483 | 1.00 | PDE4A (0.73) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Glucuronic Acid SCHEMBL10823159 | 1.00 | PDE4A (0.73) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL4389427 | 1.00 | PDE4A (0.73) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Gluconic Acid SCHEMBL20815121 | 1.00 | PDE4A (0.73) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| Glucuronic Acid SCHEMBL7089004 | 1.00 | PDE4A (0.73) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1896601-A1 | BIOACTIVE AGENTS PRODUCED BY SUBMERGED CULTIVATION OF A BASIDIOMYCETE CELL | Medimush A/S (DK) | 2008-03-12 | — | — | EP | claimed |
| WO-2006133708-A1 | BIOACTIVE AGENTS PRODUCED BY SUBMERGED CULTIVATION OF A BASIDIOMYCETE CELL | MEDIMUSH A/S (DK) | 2006-12-21 | — | — | WO | claimed |
| CN-112266398-B | Key disaccharide repeating unit of glucuronic acid mannan oligosaccharide and preparation method thereof | 中国科学院海洋研究所 | 2022-10-04 | — | — | CN | disclosed |
| CN-112266398-A | Key disaccharide repeating unit of glucuronic acid mannan oligosaccharide and preparation method thereof | 中国科学院海洋研究所 | 2021-01-26 | — | — | CN | disclosed |
| US-10729714-B2 | Basidiomycete-derived cream for treatment of skin diseases | GLYCANOVA AS (NO) | 2020-08-04 | — | — | US | disclosed |
| EP-2953628-B1 | BASIDIOMYCETE-DERIVED CREAM FOR TREATMENT OF SKIN DISEASES | GLYCANOVA AS (NO) | 2018-10-10 | — | — | EP | disclosed |
| US-20170304415-A1 | Anti-Cancer Combination Treatment and Kit-of-Parts | GLYCANOVA AS (NO) | 2017-10-26 | — | — | US | disclosed |
| US-20160022786-A1 | Anti-Cancer Combination Treatment and Kit-of-Parts | MEDIMUSH A/S (DK) | 2016-01-28 | — | — | US | disclosed |
| US-20160015734-A1 | Basidiomycete-Derived Cream for Treatment of Skin Diseases | GLYCANOVA AS (NO) | 2016-01-21 | — | — | US | disclosed |
| EP-2953628-A1 | BASIDIOMYCETE-DERIVED CREAM FOR TREATMENT OF SKIN DISEASES | Glycanova AS (NO) | 2015-12-16 | — | — | EP | disclosed |
| US-9072776-B2 | Anti-cancer combination treatment and kit-of-parts | GLYCANOVA AS (NO) | 2015-07-07 | — | — | US | disclosed |
| US-20100086647-A1 | FEED OR FOOD PRODUCTS COMPRISING FUNGAL MATERIAL | MEDIMUSH AS (DK) | 2010-04-08 | — | — | US | disclosed |
| US-20090143280-A1 | ANTI-CANCER COMBINATION TREATMENT AND KIT-OF-PARTS | MEDIMUSH A/S (DK) | 2009-06-04 | — | — | US | disclosed |
| US-20090005340-A1 | Bioactive Agents Produced By Submerged Cultivation of a Basidiomycete Cell | MEDIMUSH A/S (DK) | 2009-01-01 | — | — | US | disclosed |
| EP-1896600-A2 | ANTI-CANCER COMBINATION TREATMENT AND KIT-OF-PART | Medimush A/S (DK) | 2008-03-12 | — | — | EP | disclosed |
| EP-1896601-A1 | BIOACTIVE AGENTS PRODUCED BY SUBMERGED CULTIVATION OF A BASIDIOMYCETE CELL | Medimush A/S (DK) | 2008-03-12 | — | — | EP | disclosed |
| EP-1885866-A1 | FEED OR FOOD PRODUCTS COMPRISING FUNGAL MATERIAL | Medimush A/S (DK) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006133707-A2 | ANTI-CANCER COMBINATION TREATMENT AND KIT-OF-PART | MEDIMUSH A/S (DK) | 2006-12-21 | — | — | WO | disclosed |
| WO-2006133708-A1 | BIOACTIVE AGENTS PRODUCED BY SUBMERGED CULTIVATION OF A BASIDIOMYCETE CELL | MEDIMUSH A/S (DK) | 2006-12-21 | — | — | WO | disclosed |
| WO-2006119774-A1 | FEED OR FOOD PRODUCTS COMPRISING FUNGAL MATERIAL | MEDIMUSH AS (DK) | 2006-11-16 | — | — | WO | disclosed |